Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-09-056369

Director sold 133,576 shares at an average $11.52 ($1,538,353)

From the SEC's structured data for this filing

Trades in this filing

KARABELAS ARGERIS N · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2009-12-08 Sale : show line 1 in the form −26,376 $11.30 $298,049 536,124 I
2009-12-09 Sale : show line 2 in the form −107,200 $11.57 $1,240,304 428,924 I
Open-market sales · 133,576 sh · avg $11.52 · $1,538,353
Loading xslF345X03/c93569_4x0.xml…